RHOA and hepatocellular carcinoma: As a result of our collective present data, we therefore propose herein a molecular model, in which miR-101 broadly abrogates HCC tumorigenesis and metastasis by a direct suppression of multiple molecular targets and an inactivation of the RhoA/ROCK pathway (Fig. 5D).